Abstract
"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 638-640 |
Number of pages | 3 |
Journal | Cell |
Volume | 144 |
Issue number | 5 |
DOIs | |
State | Published - Mar 4 2011 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)